Insight Molecular Diagnostics, Inc. (IMDX)
4.14
+0.13
(+3.24%)
USD |
NASDAQ |
Sep 22, 16:00
4.115
-0.02
(-0.60%)
After-Hours: 20:00
Insight Molecular Diagnostics Market Cap : 135.06M for Sept. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 22, 2026 | 135.06M |
| September 21, 2026 | 130.82M |
| September 18, 2026 | 130.49M |
| September 17, 2026 | 128.86M |
| September 16, 2026 | 116.79M |
| September 15, 2026 | 131.14M |
| September 14, 2026 | 131.14M |
| September 11, 2026 | 137.02M |
| September 10, 2026 | 129.84M |
| September 09, 2026 | 133.75M |
| September 08, 2026 | 139.30M |
| September 04, 2026 | 134.73M |
| September 03, 2026 | 134.41M |
| September 02, 2026 | 130.82M |
| September 01, 2026 | 125.27M |
| August 31, 2026 | 127.88M |
| August 28, 2026 | 134.73M |
| August 27, 2026 | 139.95M |
| August 26, 2026 | 140.28M |
| August 25, 2026 | 144.85M |
| August 24, 2026 | 140.93M |
| August 21, 2026 | 141.58M |
| August 20, 2026 | 140.28M |
| August 19, 2026 | 142.89M |
| August 18, 2026 | 139.63M |
| Date | Value |
|---|---|
| August 17, 2026 | 139.30M |
| August 14, 2026 | 140.93M |
| August 13, 2026 | 121.03M |
| August 12, 2026 | 146.80M |
| August 11, 2026 | 144.52M |
| August 10, 2026 | 155.61M |
| August 07, 2026 | 157.57M |
| August 06, 2026 | 156.59M |
| August 05, 2026 | 161.43M |
| August 04, 2026 | 165.30M |
| August 03, 2026 | 162.40M |
| July 31, 2026 | 150.13M |
| July 30, 2026 | 148.52M |
| July 29, 2026 | 141.09M |
| July 28, 2026 | 148.84M |
| July 27, 2026 | 151.74M |
| July 24, 2026 | 153.04M |
| July 23, 2026 | 160.14M |
| July 22, 2026 | 161.11M |
| July 21, 2026 | 161.43M |
| July 20, 2026 | 156.26M |
| July 17, 2026 | 153.04M |
| July 16, 2026 | 152.07M |
| July 15, 2026 | 155.62M |
| July 14, 2026 | 144.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 337.69M |
| Agenus, Inc. | 370.76M |
| Amgen, Inc. | 221.78B |
| Anika Therapeutics, Inc. | 279.57M |
| BioCryst Pharmaceuticals, Inc. | 2.241B |
Market Cap Related Metrics
| PS Ratio | 83.90 |
| Price | 4.14 |
| Earnings Yield | -35.88% |